Renew Vitality names its operating company, says in the same sentence what kind of provider it is, carries a legal page dated within six months — and publishes no price on any page this pass could read.
What Renew Vitality charges
Renew Vitality does not publish a price today.
Renew Vitality also sells 4 compounds this site boards without publishing a price for them: Sermorelin, Ipamorelin (board ranks no provider), PT-141 and NAD+.
Renew Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
A current legal page, which is rarer than it should be
The terms carry an effective date within six months of this review. Several sellers in this batch publish legal pages one, two or nearly three years stale, and one publishes none at all.
The same opening sentence names the operating company and describes it as a telemedicine healthcare provider offering hormone replacement services. Entity and self-description arrive together, which is efficient and unusual.
It also describes how its prescribers build a plan, combining approved medications with compounded ones, in a sentence that draws the category distinction rather than blurring it.
Nothing is priced
The joined text of the peptide therapy page and of the terms contains no dollar amount at all.
That is a joined-text census rather than a per-element one, so this is a real absence and not the artefact that manufactures false ones. It is also scoped: it is what the two pages read publish, not a claim about the whole site.
Four compounds this site tracks are named across those pages. None carries a figure.
Depth without disclosure
The peptide pages sit several levels beneath the hormone service, which makes the catalogue awkward to census and easy to under-count.
No dispensing pharmacy is named. No state coverage is published, which for a telemedicine provider is the single most useful thing it could publish and does not.
No certificate or testing document is claimed, which keeps the disclosure internally consistent.
Who it's for
Readers who want a named company and a legal page that has been touched recently.
Buyers who want the approved-versus-compounded distinction drawn in the terms.
Anyone who prefers a hormone practice that treats peptides as an adjacent service.
Shoppers willing to ask for a quote.
Who should look elsewhere
Anyone comparing prices.
Readers who need the dispensing pharmacy named.
Buyers who need to know which states a telemedicine provider covers.
Shoppers wanting the peptide catalogue on one page.
Strengths
Names its operating company and states what kind of provider it is in the same sentence
Carries a terms page dated within six months, which most of this batch does not
Publishes a dedicated sermorelin therapy page under its hormone service
Says its prescribers build a plan combining approved and compounded medications
Trade-offs
Publishes no price for anything
Names no dispensing pharmacy
Publishes no state coverage
The peptide pages sit several levels below the hormone service, so the catalogue is hard to census
How we verified this
Fetched the sermorelin therapy page and the terms of service with a full browser user-agent, comparing the effective URL to the requested one on both.
Fired a nonsense-path control at the host in the same run; it returned an honest not-found status.
Joined the text nodes before matching and confirmed neither page carries a dollar amount.
Scoped the absence to the two pages read rather than asserting the seller publishes no price anywhere.
Read the operating company and the self-description out of the opening sentence of the terms.
Recorded the terms' effective date as published.
Screened the operating company against the regulator's live warning-letter index, with a known-positive and a nonsense control in the same run.
A provider to compare Renew Vitality against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.